Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Lloyd

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Journal of Medicinal Chemistry|March 14, 2012
Discovery of ((S)-5-(methoxymethyl)-7-(1-methyl-1H-indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-a]pyrimidin-6-yl)((S)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone as a potent and selective I(Kur) inhibitorHeather J Finlay, John Lloyd, Wayne Vaccaro, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2003
Tetrahydronaphthalene-derived amino alcohols and amino ketones as potent and selective inhibitors of the delayed rectifier potassium current IKsSaleem Ahmad, Lidia Doweyko, Aaila Ashfaq, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
N-[1-Aryl-2-(1-imidazolo)ethyl]-guanidine derivatives as potent inhibitors of the bovine mitochondrial F1F0 ATP hydrolaseKarnail S Atwal, Saleem Ahmad, Charles Z Ding, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 12, 2019
QTL × environment interactions underlie adaptive divergence in switchgrass across a large latitudinal gradientDavid B Lowry, John T Lovell, Li Zhang, et al.
Journal of Medicinal Chemistry|January 29, 2020
Identification of Reversible Small Molecule Inhibitors of Endothelial Lipase (EL) That Demonstrate HDL-C Increase In VivoGeorge Tora, Soong-Hoon Kim, Zulan Pi, et al.
Journal of Medicinal Chemistry|April 19, 2017
Selective I<sub>Kur</sub> Inhibitors for the Potential Treatment of Atrial Fibrillation: Optimization of the Phenyl Quinazoline Series Leading to Clinical Candidate 5-[5-Phenyl-4-(pyridin-2-ylmethylamino)quinazolin-2-yl]pyridine-3-sulfonamidePrashantha Gunaga, John Lloyd, Somanadham Mummadi, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 4, 2022
A generalist-specialist trade-off between switchgrass cytotypes impacts climate adaptation and geographic rangeJoseph D Napier, Paul P Grabowski, John T Lovell, et al.
Journal of Medicinal Chemistry|October 30, 2013
Conformationally constrained ortho-anilino diaryl ureas: discovery of 1-(2-(1'-neopentylspiro[indoline-3,4'-piperidine]-1-yl)phenyl)-3-(4-(trifluoromethoxy)phenyl)urea, a potent, selective, and bioavailable P2Y1 antagonistJennifer X Qiao, Tammy C Wang, Réjean Ruel, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 3, 2025
The United Kingdom's experience of controlled donation after circulatory death direct procurement of lungs with concomitant abdominal normothermic regional perfusion with an analysis of short-term outcomesLuke John Lloyd Williams, Rachel Hogg, Miguel Angel Reyes Roque, et al.
JAMA Oncology|April 7, 2017
An International Collaborative Standardizing a Comprehensive Patient-Centered Outcomes Measurement Set for Colorectal CancerJessica A Zerillo, Maartje G Schouwenburg, Annelotte C M van Bommel, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Journal of Medicinal Chemistry|March 14, 2012
Discovery of ((S)-5-(methoxymethyl)-7-(1-methyl-1H-indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-a]pyrimidin-6-yl)((S)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone as a potent and selective I(Kur) inhibitorHeather J Finlay, John Lloyd, Wayne Vaccaro, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2003
Tetrahydronaphthalene-derived amino alcohols and amino ketones as potent and selective inhibitors of the delayed rectifier potassium current IKsSaleem Ahmad, Lidia Doweyko, Aaila Ashfaq, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2004
N-[1-Aryl-2-(1-imidazolo)ethyl]-guanidine derivatives as potent inhibitors of the bovine mitochondrial F1F0 ATP hydrolaseKarnail S Atwal, Saleem Ahmad, Charles Z Ding, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 12, 2019
QTL × environment interactions underlie adaptive divergence in switchgrass across a large latitudinal gradientDavid B Lowry, John T Lovell, Li Zhang, et al.
Journal of Medicinal Chemistry|January 29, 2020
Identification of Reversible Small Molecule Inhibitors of Endothelial Lipase (EL) That Demonstrate HDL-C Increase In VivoGeorge Tora, Soong-Hoon Kim, Zulan Pi, et al.
Journal of Medicinal Chemistry|April 19, 2017
Selective I<sub>Kur</sub> Inhibitors for the Potential Treatment of Atrial Fibrillation: Optimization of the Phenyl Quinazoline Series Leading to Clinical Candidate 5-[5-Phenyl-4-(pyridin-2-ylmethylamino)quinazolin-2-yl]pyridine-3-sulfonamidePrashantha Gunaga, John Lloyd, Somanadham Mummadi, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 4, 2022
A generalist-specialist trade-off between switchgrass cytotypes impacts climate adaptation and geographic rangeJoseph D Napier, Paul P Grabowski, John T Lovell, et al.
Journal of Medicinal Chemistry|October 30, 2013
Conformationally constrained ortho-anilino diaryl ureas: discovery of 1-(2-(1'-neopentylspiro[indoline-3,4'-piperidine]-1-yl)phenyl)-3-(4-(trifluoromethoxy)phenyl)urea, a potent, selective, and bioavailable P2Y1 antagonistJennifer X Qiao, Tammy C Wang, Réjean Ruel, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 3, 2025
The United Kingdom's experience of controlled donation after circulatory death direct procurement of lungs with concomitant abdominal normothermic regional perfusion with an analysis of short-term outcomesLuke John Lloyd Williams, Rachel Hogg, Miguel Angel Reyes Roque, et al.
JAMA Oncology|April 7, 2017
An International Collaborative Standardizing a Comprehensive Patient-Centered Outcomes Measurement Set for Colorectal CancerJessica A Zerillo, Maartje G Schouwenburg, Annelotte C M van Bommel, et al.
Pageof 9